WEED Stock Overview
Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Canopy Growth Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$8.84 |
52 Week High | CA$26.00 |
52 Week Low | CA$3.74 |
Beta | 1.74 |
11 Month Change | -23.73% |
3 Month Change | -24.19% |
1 Year Change | 73.33% |
33 Year Change | -96.92% |
5 Year Change | -98.32% |
Change since IPO | -65.87% |
Recent News & Updates
Recent updates
Some Confidence Is Lacking In Canopy Growth Corporation (TSE:WEED) As Shares Slide 26%
Jun 15Canopy Growth Corporation's (TSE:WEED) 77% Share Price Surge Not Quite Adding Up
Apr 20More Unpleasant Surprises Could Be In Store For Canopy Growth Corporation's (TSE:WEED) Shares After Tumbling 28%
Feb 23Analysts Have Been Trimming Their Canopy Growth Corporation (TSE:WEED) Price Target After Its Latest Report
Feb 13Why We're Not Concerned Yet About Canopy Growth Corporation's (TSE:WEED) 42% Share Price Plunge
Dec 22Is Canopy Growth (TSE:WEED) A Risky Investment?
Sep 17With A 31% Price Drop For Canopy Growth Corporation (TSE:WEED) You'll Still Get What You Pay For
Apr 17Is Canopy Growth (TSE:WEED) Using Too Much Debt?
Mar 21Earnings Update: Canopy Growth Corporation (TSE:WEED) Just Reported And Analysts Are Trimming Their Forecasts
Feb 12Is Canopy Growth (TSE:WEED) Using Too Much Debt?
Dec 08Shareholder Returns
WEED | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | -5.9% | -0.8% | 1.4% |
1Y | 73.3% | 33.2% | 8.4% |
Return vs Industry: WEED exceeded the Canadian Pharmaceuticals industry which returned 33.2% over the past year.
Return vs Market: WEED exceeded the Canadian Market which returned 8.4% over the past year.
Price Volatility
WEED volatility | |
---|---|
WEED Average Weekly Movement | 28.4% |
Pharmaceuticals Industry Average Movement | 13.1% |
Market Average Movement | 8.2% |
10% most volatile stocks in CA Market | 16.7% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: WEED's share price has been volatile over the past 3 months.
Volatility Over Time: WEED's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 1,029 | David Klein | www.canopygrowth.com |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices.
Canopy Growth Corporation Fundamentals Summary
WEED fundamental statistics | |
---|---|
Market cap | CA$697.97m |
Earnings (TTM) | -CA$483.68m |
Revenue (TTM) | CA$297.15m |
2.3x
P/S Ratio-1.4x
P/E RatioIs WEED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
WEED income statement (TTM) | |
---|---|
Revenue | CA$297.15m |
Cost of Revenue | CA$217.25m |
Gross Profit | CA$79.90m |
Other Expenses | CA$563.58m |
Earnings | -CA$483.68m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -6.35 |
Gross Margin | 26.89% |
Net Profit Margin | -162.78% |
Debt/Equity Ratio | 119.3% |
How did WEED perform over the long term?
See historical performance and comparison